Research abstract
Article abstract
Nature Biotechnology 25, 903 - 910 (2007)
Published online: 29 July 2007 | Corrected online: 11 March 2008 | doi:10.1038/nbt1326
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice
Hisaya Azuma1, Nicole Paulk1, Aarati Ranade2, Craig Dorrell1, Muhsen Al-Dhalimy1, Ewa Ellis2, Stephen Strom2, Mark A Kay3, Milton Finegold4 & Markus Grompe1
Abstract
Mice that could be highly repopulated with human hepatocytes would have many potential uses in drug development and research applications. The best available model of liver humanization, the uroplasminogen-activator transgenic model, has major practical limitations. To provide a broadly useful hepatic xenorepopulation system, we generated severely immunodeficient, fumarylacetoacetate hydrolase (Fah)-deficient mice. After pretreatment with a urokinase-expressing adenovirus, these animals could be highly engrafted (up to 90%) with human hepatocytes from multiple sources, including liver biopsies. Furthermore, human cells could be serially transplanted from primary donors and repopulate the liver for at least four sequential rounds. The expanded cells displayed typical human drug metabolism. This system provides a robust platform to produce high-quality human hepatocytes for tissue culture. It may also be useful for testing the toxicity of drug metabolites and for evaluating pathogens dependent on human liver cells for replication.
- Oregon Stem Cell Center, Oregon Health & Science University, Portland, Oregon 97239, USA.
- Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15261, USA.
- Department of Pediatrics, Stanford University, California 94305, USA.
- Department of Pathology, Texas Children's Hospital, Baylor College of Medicine, 77030 Houston, Texas, USA.
Correspondence to: Markus Grompe1 e-mail: grompem@ohsu.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
A human hepatocyte factoryNature Biotechnology News and Views (01 Aug 2007)
Round two for liver gene therapyNature Genetics News and Views (01 Mar 1996)
Fah−/−/RESEARCH
Cell fusion is the principal source of bone-marrow-derived hepatocytesNature Letters to Editor (24 Apr 2003)
Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytesNature Medicine Article (01 Oct 1998)
Fah−/−/
